BPOM Regulation No. 10 of 2022 concerning Guidelines for Preclinical In Vivo Toxicity Testing

This guideline is designed for preclinical toxicity testing in the development of new drugs, natural medicines, quasi-drugs, health supplements, cosmetics, and processed foods. It serves as a resource for research institutions, product developers, and other stakeholders involved in these areas.